3D - search results
If you're not happy with the results, please do another search
Researchers 3D-print hydrodynamic model of aortic stenosis and ventricular remodelling
Massachusetts Institute of Technology engineers have created a soft robotics-enabled three-dimensional (3D)-printed anatomical hydrodynamic system that can recreate the hemodynamic system of aortic stenosis...
Biotronik gains CE mark for Selectra 3D implant tools to include left bundle branch...
Biotronik has received CE mark approval for the Selectra 3D implant tools to include left bundle branch area pacing (LBBAP) in addition to His-bundle...
Field Medical and CardioNXT to collaborate on 3D integrated PFA therapy
Field Medical and CardioNXT have announced a strategic collaboration to provide the first-of-its-kind focal pulsed field ablation (PFA) therapy integrated with 3D mapping &...
FDA approval granted for inHEART 3D imaging analysis software
inHEART has received US Food and Drug Administration (FDA) 510(k) clearance for its inHEART Models software suite that enables 3D visualisation and analysis of...
First patient treated with VeriSight Pro 3D intracardiac echocardiography catheter
Royal Philips has announced the first procedure using its real-time 3D intracardiac echocardiography (ICE) catheter. The left atrial appendage occlusion (LAAO) procedure was carried...
First patients treated using integrated navigation technology from Stereotaxis and ADAS 3D
Stereotaxis and ADAS 3D Medical have announced that the first patients have been treated with the integration of ADAS 3D’s advanced preoperative substrate mapping...
Siemens Healthineers and Imricor to partner for 3D MRI-guided cardiac ablation system
Siemens Healthineers is joining forces with Imricor Medical Systems to develop an integrated system that combines the clinical benefits of real-time magnetic resonance imaging...
ADVERTORIAL: Experience with the ColumbusTM 3D EP Navigation System in the Dominican Republic
Electrophysiologists Manuel Ayala Patete, Dulce Garcia, Mikel Liñero, Vanesa Burgos and Carlos Garcia Lithgow, all from Centro Cardio-Neuro-Oftalmologico y Transplante (CECANOT) in Santo Domingo,...
US FDA clears CardioInsight noninvasive 3D mapping system
Medtronic has received US Food and Drug Administration (FDA) 510(k) clearance for the CardioInsight noninvasive 3D mapping system. The CardioInsight system is used to...
Acutus Medical granted CE mark for AcQMap 3D
Acutus Medical has received CE mark approval for its AcQMap high resolution imaging and mapping system, and for its AcQMap catheter.
APN Health granted FDA clearance for Navid 3D cardiac mapping system
The system produces real-time 3D catheter location information from 2D fluoroscopic images of the heart, and correlates them with the electrical activation of the heart.
Topera’s third generation 3D Mapping System is FDA cleared
The new system processes information in seconds, providing near-instantaneous intra-procedural mapping and re-mapping capabilities. In addition, the system incorporates a new color-imaging module to aid identification of "Rotors," an electrophysiologic phenomenon previously shown to sustain atrial fibrillation.
FDA clears Firmap catheter and RhythmView 3D mapping workstation
On 7 November, Topera announced receiving 510(k) clearance by the FDA for the Firmap catheter and the RhythmView 3D mapping workstation. This technology has been developed for the identification of the sources that sustain complex cardiac arrhythmias.
“This is a very good time to hop on the wagon and learn about...
Roberto M Lang, professor of Medicine, University of Chicago Medical Center, Chicago, USA, is a pioneer in the development of 3D echocardiography. Lang, who...
SentiAR closes Series B financing round
SentiAR has closed a Series B financing round worth US$8.5 million. The financing was led by cultivate (MD) Ventures and joined by MedVenture Partners...
HeartBeam accquires LIVMOR assets
HeartBeam, a cardiac technology company that has developed the three-dimensional (3D)-vector electrocardiogram (VECG) platform for heart attack detection today announced the strategic acquisition of...
Periodontitis linked to increased risk of AF in Japanese study
Researchers have found a correlation between periodontitis and fibrosis scarring to an appendage of the heart’s left atrium that can lead to atrial fibrillation...
HeartBeam granted European patent for signal transformation from VECG to 12-lead ECG
HeartBeam, a cardiac technology company that has developed a 3D-vector electrocardiogram (ECG) platform for heart attack detection, has announced that a patent that enables...
Volta Medical secures multimillion Euro series B funding round
Volta Medical has announced €36 million in new series B funding, bringing the total capital raised to over €70 million.
The company is developing artificial...
HeartBeam granted patent for electrocardiogram smartwatch that detects MI and arrhythmias
HeartBeam, a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform for heart attack detection has announced that its...
First patients treated in study of Globe pulsed field ablation system
Kardium has announced the successful first-in-human study of its next generation Globe pulsed field system to treat atrial fibrillation (AF) using pulsed field ablation...
Heliostar radiofrequency balloon ablation catheter gets European launch
Biosense Webster has announced the European launch of the Heliostar radiofrequency balloon ablation catheter. Heliostar is indicated for use in catheter-based cardiac electrophysiological mapping...
Japanese approval of Acutus imaging and mapping systems
Acutus Medical has announced approval of its AcQMap high resolution imaging and mapping system and the AcQMap 3D imaging and mapping catheter in Japan.
Acutus’...
Abbott’s Ensite X mapping system available in Canada
Abbott has introduced its EnSite X EP a cardiac mapping platform with EnSite Omnipolar Technology (OT) in Canada.
The platform allows for the creation of...
CathVision completes enrolment in ECGenius study
CathVision has completed patient enrolment in the CathVision ECGenius System clinical evaluation study at the University of Vermont Medical Center (Burlington, USA). The study...
AcQForce PFA-CE study begins for focal PFA therapy to treat atrial fibrillation
Acutus Medical has announced the initiation of AcQForce PFA-CE, a clinical study that will evaluate the safety and performance of the company’s focal force...
Robotics in the EP lab: Pointing the way to the future
Benjamin D’Souza, assistant professor of Medicine at the University of Pennsylvania, cardiac electrophysiologist at Penn Presbyterian Medical Center, Philadelphia, USA, discusses the recent developments...
Targeting atrial fibrosis in AF patients with low levels of disease “may help improve...
Image-guided fibrosis ablation in addition to pulmonary vein isolation (PVI) does not improve ablation success rates compared to PVI alone in patients with persistent...
CardioNXT gains FDA marketing clearance for heart treatment delivery platform
CardioNXT has received marketing clearance from the US Food and Drug Administration (FDA) for the platform technology comprised of the iMap 3D Navigation &...
Acutus receives FDA and CE mark approvals for AcQMap 8
Acutus Medical has received US Food and Drug Administration (FDA) and CE mark clearance for its suite of software upgrades known collectively as AcQMap...
AliveCor and Acutus partner for post-market study
AliveCor and Acutus Medical will collaborate to assess the integration of data collection tools across the cardiology continuum of care, which the companies say...
Single-shot pulsed-field ablation yields “excellent” PVI durability
Pulmonary vein isolation (PVI) with a “single-shot” pulsed-field ablation (PFA) catheter results in excellent PVI durability and acceptable safety with a low one-year rate...
US enrolment in AcQForce Flutter IDE clinical trial commences
Acutus Medical has announced initial US enrolment in the company’s AcQForce Flutter Investigational Device Exemption (IDE) clinical trial. The trial is expected to enrol...
AF Symposium 2021: Experts debate early ablation strategy in AF
The merits of catheter ablation as a first-line treatment for atrial fibrillation (AF) were considered during the second day of AF Symposium 2021 (29–31...
AF Symposium 2021: Two cases highlight Acutus’ mapping technology
Acutus Medical has announced a number presentations relating to its mapping and ablation procedures during 26th Annual International AF Symposium (29–31 January, virtual). The...
Kardium secures financing to advance Globe mapping and ablation system
Kardium has raised US$115 million in a new financing round, which will be used to accelerate commercial growth of the Globe mapping and ablation...
Volta Medical’s VX1 AI software for use in AF mapping now FDA cleared
Volta Medical has announced that it has obtained US Food and Drug Administration (FDA) clearance for its VX1 AI (artificial intelligence) software. According to...
Acutus Medical launches the AcQBlate force sensing ablation system in Europe
Acutus Medical has announced the launch of the AcQBlate force sensing ablation system in Europe after securing CE mark for the company’s AcQBlate FORCE...
Kardium announces first clinical use of Globe Positioning System
Kardium has announced the first clinical use of the Globe Positioning System—a 3D mapping and navigation feature of its flagship product, the Globe Mapping...
European and Australian approvals granted for Abbott’s cardiac mapping system EnSite
Abbott has announced has announced the receipt of CE mark and approval in Australia for its EnSite X EP System, and is launching the...
Rhythm AI gets green light for ROCSTAR clinical trial
Rhythm AI has today announced that it has received approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to proceed with its...
Holographic ablation guidance system gains US FDA clearance
SentiAR has received US Food and Drug Administration (FDA) 510(k) clearance for its CommandEP system, the first holographic guidance system to be used during...
US FDA approval for second generation AcQMap system
Acutus Medical has announces US Food and Drug Administration (FDA) 510(k) clearance of the second-generation AcQMap 3D imaging and mapping catheter which builds on...
Philips launches latest version of its Azurion imaging platform
Royal Philips has announced the next-generation of its Azurion image-guided therapy platform, designed to improve the quality and efficiency of interventional procedures. The Azurion...
Biosense Webster launches latest generation of Carto heart mapping system
Johnson & Johnson Medical Devices Companies has today announced the launch of Biosense Webster’s Carto 3 system version 7 and the Carto Prime mapping...
Philips announces new imaging enhancements for Kodex-EPD system
Royal Philips has announced new imaging and workflow enhancements for its Kodex-EPD cardiac imaging and mapping system. The system is used to treat patients...
Using advanced imaging to tackle complex arrhythmias
J Peter Weiss (Heart Institute, Banner University of Arizona Medical Center, Phoenix, USA) outlines his experience of the AcQMap (Acutus Medical) 3D imaging and...
Holographic display may improve physician accuracy during cardiac ablation
Details of the first-in-human use of an augmented reality holographic display to aid physician accuracy during cardiac ablation have been published in the Journal...
Paper highlights use of robotic system for catheter ablation in COVID-19 patients
Stereotaxis has announced the publication of a paper in the European Heart Journal highlighting the benefits of using robotic technology for the management of...
Athena Poppas
Athena Poppas is chief of cardiology at the Alpert Medical School of Brown University (Providence, USA) and has recently begun her term as the...
NuVera announces successful first-in-human use of NuVision ICE catheter
NuVera Medical has announced the initiation of the company's first-in-human clinical trial to evaluate the performance of its NuVision intracardiac echocardiography (ICE) catheter. The...
€3.7m funding round completed for cardiac AI developer inHEART
inHEART, developer of a cloud-based medical image analysis solution for cardiac interventions on patients with arrhythmias, has closed a funding round of €3.7m led...
Philips gains FDA clearance for the use of its ultrasound portfolio to manage COVID-19...
Royal Philips has announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market a wide range of...
Value of augmented reality goes well beyond holograms in the electrophysiology lab
Jennifer Silva (St Louis, USA) talks to BLearning Cardio at SIR 2019 (Society of Interventional Radiology; 23–28 March; Austin, USA) about why physicians should...
RHYTHM AI to collaborate with Biosense Webster on STAR Mapping clinical trial
RHYTHM AI has announced the signing of a research collaboration agreement with Biosense Webster. A press release from RHYTHM AI outlines that the agreement...
AF Symposium 2020: Acutus Medical live streams case using AcQMap System
Acutus Medical offered a demonstration of its AcQMap advanced cardiac imaging and mapping system at AF Symposium (23–25 January, Washington, DC, USA) with a live-stream...
Cardiac Rhythm News Issue 46 – October 2019
Highlights:
ESC guidelines on supraventricular tachycardias underline the pivotal role of catheter ablation therapy
Study suggests increased use of DOACs in AF leads to...
HRC 2019: Post-implantation QRS area is a better predictor of cardiac mortality after CRT...
Osita Okafor (Aston University, Birmingham, UK) presented an oral abstract this week at the Heart Rhythm Congress (HRC 2019; 6–9 October, Birmingham, UK) that...
Philips debuts innovations in ultrasound and enterprise informatics to advance cardiac care at ESC...
Philips is showcasing its latest cardiac care innovations at the ESC Congress 2019 (European Society of Cardiology; 31 August–4 September, Paris, France). At the...
Philips announces new advanced automation capabilities for its EPIQ CVx and EPIQ CVxi cardiac...
A Philips press release reports both the EPIQ CVx and EPIQ CVxi now include automated applications for 2D assessment of the heart, as well...
Acutus Medical’s new contact mapping software receives CE mark
Acutus Medical recently announced CE mark approval for AcQMap contact mapping software, offering expanded functionality that provides physicians with more options to inform individualised...
Mapping dynamic patterns during atrial fibrillation can produce higher success rates
In a late breaking session at the 2019 AF Symposium in Boston, USA (24–26 January), it was announced that a dipole density (DD) mapping...
New option available for physicians treating patients with atrial fibrillation
Approval has been granted for Abbot’s TactiCath Contact Force Ablation Catheter, Sensor Enabled, which is helping more physicians integrate ablation with 3D mapping to...
Tim Betts
For Tim Betts, a career in medicine was a natural choice. After graduating he knew he wanted to be a cardiologist and, with a...
New cardiac ultrasound solutions with anatomical intelligence launched
Royal Philips has introduced the EPIQ CVx cardiovascular ultrasound system. Built on the powerful EPIQ ultrasound platform, EPIQ CVx is specifically designed to increase...
Philips expands its cardiac rhythm portfolio with the acquisition of EPD Solutions
Royal Philips has announced that it has signed an agreement to acquire EPD Solutions. EPD’s cardiac imaging and navigation system helps electrophysiologists navigate the...
Advisor HD Grid mapping catheter, sensor enabled, gains FDA clearance
Abbott has announced US Food and Drug Administration (FDA) clearance of the Advisor HD Grid mapping catheter, sensor enabled. Advisor HD Grid employs a new...
DEEP-guided ablation may enable better treatment of ventricular tachycardia
Results from a multicentre study of catheter ablation guided by DEEP (decrement-evoke potential) mapping show that using DEEP mapping meant that ablation was successful...
Brain MRI scans can inform the choice between OACs and LAA closure for non-valvular...
M Edip Gurol is a stroke neurologist with particular expertise in the care of patients at high risk for ischaemic (blockage type) strokes and...
Medtronic: class I recall- manufacturing error preventing electrical shock delivery
Medtronic is recalling certain implantable cardioverter defibrillators (ICDs) and cardiac resynchronisation therapy defibrillators (CRT-Ds) due to a defect in the manufacturing process. This defect...
EPD obtains European regulatory approval for its cardiac mapping and navigation system
EPD’s Cardiac Mapping and Navigation System has received CE mark approval. The system helps electrophysiologists navigate the heart by generating an accurate 3D map,...
New data demonstrates >90% year 1 success rate for radiofrequency ablation in treating patients...
Biosense Webster, a Division of Johnson & Johnson Medical NV/SA, and a leader in the diagnosis and treatment of cardiac arrhythmias, recently presented new...
Imaging-based simulations for predicting sudden death and guiding ablation
Natalia Trayanova envisions the future of cardiology and electrophysiology advancing through personalised medicine and computational simulations. Trayanova is the director of the Computational Cardiology...
Nearly 25% of chronic ischaemic heart disease patients dead or hospitalised in six months
Nearly a quarter of patients with chronic ischaemic cardiovascular disease are dead or hospitalised within six months, reports a European Society of Cardiology (ESC) study...
Imricor announces new developments in MR compatible ablation products
Imricor is developing a magnetic resonance (MR) compatible injection catheter and has announced a joint development agreement with MiRTLE Medical to integrate MiRTLE’s MR...
Real-time cardiac mapping technology cleared by FDA
Acutus Medical has announced that the US Food and Drug Administration (FDA) cleared the AcQMap high resolution imaging and mapping system as well as...
Sabine Ernst
Sabine Ernst (lead electrophysiology research/consultant cardiologist, Royal Brompton and Harefield Hospital, London, UK and associate lead for Cardiac Imaging in the Biomedical Research Unit...
ESC 2017: EHRA and Biotronik mark 10 years of collaboration with the EHRA White...
At the European Society of Cardiology (ESC) congress (26–30 August, Barcelona, Spain), the European Heart Rhythm Association (EHRA) released an analytical supplement to the...
Cardiac resynchronisation therapy guided by imaging: The next step for optimal left ventricular lead...
Jonathan Behar (London, UK) co-inventor for the Guide CRT platform—shortlisted as a 2017 finalist for the EHRA Inventors Award—details the benefits of this novel...
EHRA Inventors Award ideas focus on cardiac remote monitoring and CRT optimisation
For the second-year running, the European Heart Rhythm Association (EHRA) held the EHRA Inventors Award competition at EHRA-EUROPACE CARDIOSTIM (18‒21 June, Vienna, Austria), a...
Acutus Medical receives FDA clearance for AcQGuide Steerable Sheath
Acutus Medical has announced the FDA clearance of the AcQGuide Steerable Sheath, which marks the first US regulatory milestone for the company. The AcQGuide Steerable...
US FDA approves Abbott’s FlexAbility Catheter, Sensor Enabled
The FlexAbility Ablation Catheter, Sensor Enabled is designed to improve the versatility and precision during cardiac ablation procedures to treat atrial flutter.
The Sensor Enabled...
Biotronik to host 10th annual “Expert Meeting Berlin”
For the tenth year in a row, Biotronik is hosting the “Expert Meeting Berlin” (EMB). Led by Christopher Piorkowski, Heart Center Dresden, Germany, the...
Discover the latest evidence and ablation techniques for persistent AF treatment
Join atrial fibrillation (AF) experts Prof Richard Schilling (St Barts Hospital, London UK), Prof Carlo de Asmundis (Universitair Ziekenhuis, Brussels, Belgium) and PD Dr...
No significant differences between Watchman and Amplatzer in first comparison
Results from the first study to compare outcomes of two left atrial appendage closure devices—Watchman (Boston Scientific) and Amplatzer (St Jude Medical)—indicate that there...
Stereotaxis releases second generation V-CAS Deflect system in Europe
Stereotaxis has announced the market release of its second generation V-CAS Deflect catheter advancement system in Europe. The V-CAS Deflect catheter advancement system is...
Relevance of imaging for ventricular tachycardia ablation
Cardiac imaging has emerged as an integral part of mapping and ablation in a variety of complex arrhythmias. Advances in imaging techniques, especially the...
MicroPort EP receives Chinese FDA approval for Columbus and FireMagic products
MicroPort EP has recently received approval from the China Food and Drug Administration (CFDA) for Columbus 3D EP navigation system and FireMagic 3D irrigated...
Etienne Aliot
Etienne Aliot (Nancy, France) has always been fascinated by the work of surgeons. This fascination set him on his path through medical school. He...
First randomised trial shows “poor outcomes” with rotor ablation
OASIS, the first randomised, controlled, multicentre clinical trial to compare rotor-only ablation with two other ablation strategies in non-paroxysmal atrial fibrillation patients found “poor...
George Van Hare
George Van Hare (The Louis Larrick Ward professor of Pediatrics and director, Division of Pediatric Cardiology, Washington University School of Medicine, St Louis, USA), has worked towards advancing paediatric electrophysiology, as a recognised specialty, in the paediatric cardiology world and the electrophysiology world. He considers that working as a paediatric electrophysiologist is a "rewarding" experience, because it has allowed him to diagnose and cure at a very early stage. He talks to C
Fluoroscopy times and radiation dose reduced in atrial fibrillation ablation with contact force-sensing technology
A real-world study has found that the SmartTouch (Biosense Webster) contact force-sensing catheter coupled with an Advanced Catheter Location feature during atrial fibrillation (AF) ablation reduced fluoroscopy times by 77%, radiation dose by 71% and procedural time by 19%.
Boston Scientific receives FDA approval for Acuity X4 quadripolar leads
The US Food and Drug Administration has granted approval to Boston Scientific for its Acuity X4 quadripolar left ventricular leads. The company can now offer its first full X4 cardiac resynchronisation system to the US market.
Stereotaxis and Philips extend development collaboration for Niobe ES and Allura Xper FD10
Stereotaxis and Philips have signed an addendum, pursuant to their existing development and cooperation agreement, to facilitate development of a new interface between each company's most advanced systems for electrophysiology and interventional cardiology procedures.
Jonathan Kalman
A leading heart rhythm expert in Australia, Jonathan M Kalman directs both clinical and research groups in the Department of Cardiac Arrhythmias at the Royal Melbourne Hospital and University of Melbourne, Australia. In this interview, he recalls details of the first curative ablation procedure for atrial fibrillation in Australia and talks about the impact of lifestyle modification in atrial fibrillation management.
New ultrasound-based system shows promise mapping atrial fibrillation
Initial findings have shown that a new ultrasound-based imaging system with continuous dipole density mapping provides real-time rapid global left atrial reconstruction and compares favourably to segmented computed tomography (CT).
New study has “major physiopathological and clinical implications” for the management of Brugada syndrome
Josep Brugada (Barcelona, Spain), Carlo Pappone (Milan, Italy) and others report in Circulation: Arrhythmia and Electrophysiology that ablation of abnormal epicardial substrate in patients with Brugada syndrome can eliminate the phenotype expression of the syndrome.
Simple test predicts obstructive sleep apnoea in patients hospitalised for heart failure
Researchers at Thomas Jefferson University, Philadelphia, USA, have showed that a simple questionnaire, evaluation and pulse-oximetry monitoring can lead to early detection of sleep apnoea in patients hospitalised for congestive heart failure.
Medtronic acquires CardioInsight Technologies
CardioInsight Technologies will now become part of the Medtronic Atrial Fibrillation Solutions business in the Cardiac Rhythm and Heart Failure division.
Biosense Webster launches Carto 3 system Confidense module
The Confidense module's proprietary algorithm streamlines data collection, annotation and validation for the market-leading Carto system.
Cryoballoon ablation is not as safe as radiofrequency but is as effective
Armin Luik presented findings at HRS 2015 indicating that cryoballoon ablation is a faster as effective as radiofrequency ablation for pulmonary vein isolation in paroxysmal atrial fibrillation patients, but has a greater complication rate and requires higher X-ray dosages.
Data shows advantages of Acutus Medical Dipole Density Heart Imaging and Mapping System in...
The data was presented at the Heart Rhythm Society's 36th Annual Scientific Sessions (13-16 May, Boston, USA) and shows the systems benefits compared with standard voltage-based mapping in patients with atrial flutter.
TomTec receives FDA 510(k) clearance for its latest version of TomTec-Arena software
TomTec-Arena is a suite of clinical applications to review, analyse and quantify medical image data in multiple dimensions (2D and 3D/4D) and multiple modalities.
Hansen Medical announces expanded protocol for the ARTISAN-AF IDE study
The amended protocol now includes the use of the Thermocool SmartTouch catheter (BioSense Webster) and the EnSite Velocity Cardiac Mapping System (St Jude Medical) in combination with the Sensei Robotic System (Hansen Medical) for the treatment of paroxysmal atrial fibrillation.
Biosense Webster launches programme to reinforce patient benefits of company’s contact force therapy
The Biosense Webster Advantage programme is an outcomes-based, risk-sharing program for US hospitals that reinforces the significant patient benefits demonstrated by the ThermoCool SmartTouch Catheter.
Biosense Webster and StopAfib.org work to raise awareness of AFIB
Biosense Webster has partnered with advocacy organisation StopAfib.org to encourage Americans to "Get SMART About Afib."
Massachussets General Hospital to coordinate new global research initiative in USA exploring genetic causes...
The Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care has announced participation as coordinating centre in the USA for a new research initiative dedicated to explore the genetic causes of atrial fibrillation as part of the Transatlantic Network of Excellence in Cardiovascular and Neurovascular Research Program.
John Muir Health’s Concord medical centre one of 20 hospitals in USA to use...
John Muir Health's Concord medical centre is one of just 20 hospitals in the USA to begin treating patients who suffer from atrial fibrillation with a new procedure that features the FDA-cleared FIRMap catheter.
Cryoballoon faster and more effective than conventional radiofrequency ablation for paroxysmal AF
A randomised controlled trial comparing three methods of pulmonary vein isolation for paroxysmal atrial fibrillation has revealed that procedures were faster and more effective with Medtronic's Arctic Front cryoballoon than wide encirclement using conventional point-by-point radiofrequency ablation. Procedures using the cryoballoon also resulted in a higher single procedure success rate.
Substrate based ablation superior than conventional ablation of stable clinical ventricular tachycardia
For stable clinical ventricular tachycardias, a substrate based ablation approach is more effective than conventional ablation preventing recurrences from any ventricular tachycardias in patients with ischaemic cardiomyopathy, according to results of the VISTA study, which is the first randomised trial performed in this area.
First reduced radiation heart procedures in Arizona with MediGuide technology
John C Lincoln North Mountain Hospital in Phoenix, Arizona, USA, is the first hospital in Arizona, and only one of eight hospitals in the USA, utilising the MediGuide technology to reduce or eliminate radiation for minimally invasive cardiac procedures, according to a press release from John C Lincoln Health Network.
Next-generation X4 quadripolar CRT-D systems are CE-marked
Boston Scientific has announced it has received CE mark approval of its X4 line of quadripolar CRT-D systems including Autogen X4, Dynagen X4, and Inogen X4 cardiac resynchronisation therapy defibrillators (CRT-Ds), a suite of Acuity X4 quadripolar left ventricular (LV) leads and the Acuity Pro lead delivery system.
CardioInsight secures financing to advance ECVUE mapping system development
CardioInsight has announced that it has completed a long-term strategic financing that provides the company with an initial investment of US$15 million.
Latin American health policies adversely affect treatment of cardiac arrhythmias in the continent
Public health expenditure in Latin America is directed mainly to tackle diseases and social problems that kill the young population but not to treat cardiac diseases (including arrhythmias), which mainly affect older people, writes Diego Vanegas, Bogota, Colombia
Idiopathic ventricular tachycardia: transcatheter ablation or antiarrhythmic drugs?
Claudio Tondo (Milan, Italy) analyses the best treatment options for different kinds of idiopathic ventricular tachycardias. He will be talking about this subject at Venice Arrhythmias (27-29 October, Venice Italy).
Sensor-based electromagnetic tracking system may help to reduce radiation exposure in CRT implantation
A new technology that uses a sensor-based electromagnetic tracking system may help to guide cardiac resynchronisation therapy (CRT) device implantation safely and potentially cut radiation exposure time as compared with traditional fluoroscopy.
AlluraClarity reduces radiation in image-guided catheter ablation trial in The Netherlands
The Catharina Hospital (Eindhoven, The Netherlands) and Royal Philips has announced the results of a clinical study involving the treatment of 136 patients with complex heart rhythm disorders such as atrial fibrillation.
FDA approval and first use of MediGuide enabled ablation catheters announced
St Jude Medical announced on 15 August that the US Food and Drug Administration (FDA) has approved its MediGuide enabled ablation catheters. The catheter can be tracked using 3D visualisation on previously recorded fluoroscopic images in real time.
FDA clears Rhythmia Mapping System
The Rhythmia Mapping System (Boston Scientific) is a next-generation 3D mapping and navigation solution for use in cardiac catheter ablations and other electrophysiology procedures to diagnose or treat cardiac arrhythmias.
Rhythmia Mapping System gets CE mark
The Rhythmia Mapping System (Boston Scientific) is a next-generation 3D mapping and navigation solution for use in cardiac catheter ablations and other electrophysiology procedures to treat cardiac arrhythmias including: atrial flutter, atrial fibrillation and ventricular tachycardia.
GE Healthcare showcases Innova EPVision 2.0 and new dose reduction technologies at HRS
GE Healthcare introduced, at HRS, the Innova EPVision 2.0 an application that combines information from EP recording and live fluoroscopy, and Dose Blueprint.
SynCardia certified centres to present Total Artificial Heart abstracts at International Society for Heart...
The topics include home discharge using the Freedom Portable Driver and the use of the Total Artificial Heart for adolescents, congenital patients and destination therapy.
GE Healthcare introduces new cardiac MRI analysis software
GE Healthcare has announced two new software packages for advanced analysis of cardiovascular magnetic resonance (MR) images: CardiacVX and MR VesselIQ Xpress.
Philips showcases advanced imaging integration in electrophysiology at Boston AF Symposium
Philips provides a novel approach to real-time 3D imaging with improved workflow and collaborates with Biosense Webster to provide enhanced anatomical detail in the Biosense Carto 3 mapping system.
Philips announces CX50 xMATRIX echocardiography system
According to the company, this is the world's first portable echocardiography system to offer real time 3D Transesophageal Echo (Live 3D TEE), which enables 3D visualisation of the cardiac structure and function as well as new perspectives of the heart in real time.
Karl-Heinz Kuck to chair Topera Medical’s International Scientific Advisory Board
Karl-Heinz Kuck is currently director of Cardiology at the Asklepios Klinik St Georg in Hamburg, Germany. He has authored more than 450 scientific papers, has served as a board member of the European Heart Rhythm Association (EHRA) for the past four years and is the current EHRA president-elect.
Biosense Webster introduces the Thermocool SF NAV catheter with Curve Visualization technology in USA
The Thermocool SF NAV catheter is designed to reduce fluoroscopy exposure to physicians, lab staff and patients alike, enhance visualisation of the ablation catheters orientation and improve procedural efficiency.
Catheter ablation of ventricular tachycardia in patients with ARVD/C significantly reduces the burden of...
A new study, published in Circulation: Arrhythmia and Electrophysiology, indicates that catheter ablation of ventricular tachycardia is an important treatment option in patients with ARVD/C, despite a high rate of ventricular tachycardia recurrence, because it reduces the burden of the arrhythmia
Steris announces collaborative alliance with St Jude Medical for advanced cardiac laboratories
These labs feature technologies across the cardiovascular service line for hospitals and clinics interested in developing state-of-the-art laboratories that meet their changing clinical needs.
Hartford Hospital Selected as a “centre of excellence” for Sensei X robotic catheter platform
This new centre of excellence, selected by Hansen Medical, will serve as the training centre for the Northern United States and is expected to commence operation in February 2012.
FDA approves Thermocool SF catheter
The Thermocool SF irrigated ablation catheter (Biosense Webster) has been approved for treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation when used with Carto systems and type 1 atrial flutter for patients 18 years and older.
Sensei X robotic catheter system to be presented at Boston AF
The Sensei X robotic catheter system (Hansel Medical) is a flexible robotic platform that integrates advanced catheter control with 3D visualisation, designed to provide catheter stability with force sensing, instinctive and precise catheter placement.
Biosense Webster and GE Healthcare sign co-distribution agreement in the USA
Under the terms of the agreement, Biosense Webster will offer a suite of GE electrophysiology systems, including CardioLab EP recording system, and GE will distribute Biosense Webster's navigation system, the Carto 3 system.
Speckle tracking echocardiography competes with MRI for infarct size quantification
"The advantages of speckle tracking echocardiography (STE) over magnetic resonance imaging (MRI) is that it is far quicker to use, cheaper, and can be used by cardiologists at the bedside with portable machines, and repeated serially when ever needed," said Luigi Badano, University of Padua, Italy.
Hansen Medical initiates clinical trial evaluating Sensei X robotic system for ventricular tachycardia
The Early robotic ablation by substrate elimination of ventricular tachycardia study (ERASE-VT), is planned to enrol 200 patients with implantable cardioverter defibrillators (ICDs) at up to eight sites in Europe.
Andrea Natale
Andrea Natale, co-president of Venice Arrhythmias (9-12 October 2011), is one of the pioneers in ablation of atrial fibrillation, he spoke to Cardiac Rhythm News about this as one of his proudest moments, he also told who inspired him into electrophysiology and what is expected for Venice Arrythmias 2011.
Biotronik announces sponsored clinical trials at ESC 2011
Biotronik announced the list of its sponsored clinical studies on remote monitoring in ICD and CRT-D patients to be presented at the European Society of Cardiology (ESC) Congress to be held in Paris, France, from 27-31 August 2011.
Biosense Webster enrols first patient in the SMART-AF IDE study
The SMART-AF investigational device exemption study is designed to demonstrate the safety and effectiveness of ThermoCool SmartTouch and FDA approved NaviStar ThermoCool catheter family, in the treatment of symptomatic, drug-refractory, paroxysmal atrial fibrillation.
Endosense and Siemens complete first patient case utilising new contact-force visualisation software
The new software is designed to give electrophysiologists access to contact-force information in a fluoroscopically enabled, three-dimensional anatomic heart model with X-ray based catheter tracking system.
Hein Heidbuchel
Hein Heidbuchel, director of Electrophysiology at the University Hospital Leuven, spoke to Cardiac Rhythm News about his career, influences and proudest moments. He also described the innovations that shaped his career, new technologies and EP education.
New AF ablation technologies: useful tools or just expensive toys?
Fiorenzo Gaita, Università degli Studi di Torino, Turin, Italy, spoke to Cardiac Rhythm news about the real impact of fluoroscopy, intracardiac echocardiography and virtual 3D electro-anatomic mapping in atrial fibrillation ablation.
FDA approves Attain Ability Plus and Attain Ability Straight left-heart leads for cardiac resynchronisation...
Attain Ability Plus enables physicians to reach and maintain the target vein, providing stability in medium-to-large venous anatomies, while Attain Ability Straight allows physicians to maneuver through small cardiac veins.
Douglas Packer
Douglas Packer spoke to Cardiac Rhythm News about his career, family, his presidency of the Heart Rhythm Society, new technologies and the CABANA trial.
Biosense starts enrolment for the REVOLUTION study for the treatment of paroximal atrial fibrillation
REVOLUTION is a prospective, multicentre, non-randomised clinical study for the evaluation of a multi-electrode pulmonary vein isolation system used to treat paroxysmal atrial fibrillation.
Endosense and Siemens Healthcare work together in development project to improve electrophysiology ablation procedures
The main goal of the shared development project is to achieve an improved visualisation of catheter-tip-to-tissue contact force within a three-dimensional anatomic heart model during catheter ablation procedures.
First clinical ablation cases in the EU using the Thermocool Smarttouch contact force sensing...
The CE-marked Thermocool Smarttouch catheter provides an important new parameter for the mapping and ablation of complex cardiac arrhythmias, such as atrial fibrillation.
Worldwide survey shows ablation works without drugs in most cases
Riccardo Cappato, Centre of Clinical Arrhythmia and Electrophysiology, Policlinico San Donato, Milan, makes his case following the second global survey on catheter ablation.
CLARITY will compare efficacy, safety and efficiency of the NaviStar ThermoCool and PVAC devices
Biosense Webster announced on 9 April 2010 that it has obtained its first Ethics Committee approval for the study in patients with paroxysmal atrial fibrillation.
More centres perform ablation for persistent and permanent AF
New observations from the Second Worldwide Survey on AF Ablation showed that more procedures are being offered every year.
Stereotaxis is notified of the FDA approval of an additional magnetic irrigated catheter
The FDA also approved all magnetic catheters for use with newly increased field strength for magnetic navigation.
New Lynx robotic irrigated ablation catheter is presented at Venice Arrhythmias
Hansen Medical showcased the small, flexible irrigated ablation catheter for the first time. CE mark is expected in the first half of 2010.
FDA approves new Medtronic left heart lead for CRT devices
Attain Ability lead is the first to use NASA technology in this kind of implantable medical device.
Robotic vs. magnetic navigation
Drs Andrea Natale and Carlo Pappone debate the merits of magnetic (Stereotaxis) or robotic (Hansen Medical) navigation for catheter ablation of atrial fibrillation.
Novel imaging technique may predict outcomes in AF patients
Researchers have found that delayed-enhancement magnetic resonance imaging holds promise for predicting treatment outcomes and measuring disease progression.
Novel imaging approach may assist in predicting success of treatment for AF
University of Utah researchers have developed a magnetic resonance imaging-based method for detecting and quantifying injury to the wall of the heart's left atrium in patients who have undergone a procedure to treat atrial fibrillation.
New imaging approach may assist in predicting success of treatment for AF
University of Utah researchers have developed a magnetic resonance imaging-based method for detecting and quantifying injury to the wall of the heart's left atrium in patients who have undergone a procedure to treat atrial fibrillation.
Robotic navigation systems in the spotlight
The use of robotic navigation in procedures to treat heart rhythm problems such as atrial flutters is gaining popularity as technology becomes more and more advanced.
